Method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse ES cell

Patent metadata

Field	Value
Publication number	US-9677129-B2
Application number	US-201414193393-A
Country	US
Kind code	B2
Filing date	Feb 28, 2014
Priority date	Oct 31, 2000
Publication date	Jun 13, 2017
Grant date	Jun 13, 2017

Abstract

A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.

First claim

We claim:

1. A method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse embryonic stem (ES) cell, the method comprising: (a) exposing the DNA of the mouse ES cell to a first probe and a second probe, wherein the first probe binds within the endogenous allele but not within the modified allele, and the second probe binds within a reference gene but not within the endogenous allele and not within the modified allele, wherein both probes generate a detectable signal upon binding, and wherein the reference gene is of known copy number; (b) detecting the signal from the binding of the first probe and the signal from the binding of the second probe; and (c) comparing the signal from the binding of the second probe to the signal from the binding of the first probe, and determining from the comparison a copy number of the endogenous allele.

2. The method of claim 1 , wherein the modified allele is orthologous to the endogenous allele.

3. The method of claim 2 , wherein the modified allele is a human allele orthologous to the endogenous allele.

4. The method of claim 1 , wherein the signal from the binding of the first probe is used to determine a first threshold cycle (Ct) value for the endogenous allele and the signal from the binding of the second probe is used to determine a second Ct value for the reference gene, and wherein copy number of the endogenous mouse allele is determined by comparing the first Ct value and the second Ct value.

5. The method of claim 1 , wherein the copy number of the endogenous allele is one.

6. The method of claim 1 , wherein the copy number of the endogenous allele is zero.

7. The method of claim 1 , wherein the Ct value of the second probe is the same in targeted ES cells as compared to the Ct value in non-targeted cells.

8. The method of claim 1 , wherein the modified allele comprises a regulatory element.

9. The method of claim 1 , wherein the modified allele comprises a protein-coding sequence.

10. The method of claim 9 , wherein the protein-coding sequence contains an alteration as compared to a protein-coding sequence within the endogenous allele.

11. The method of claim 10 , wherein the alteration is selected from the group consisting of a deletion, an insertion and a substitution.

Assignees

• Economides Aris N
• Murphy Andrew J
• Valenzuela David M
• Frendewey David
• Yancopoulos George D
• Regeneron Pharma

Inventors

• Economides Aris N
• Murphy Andrew J
• Valenzuela David M
• Frendewey David
• Yancopoulos George D

Classifications

• C12N15/79

  Vectors or expression systems specially adapted for eukaryotic hosts · CPC title

• A01K2227/105

  Murine · CPC title

• A01K67/0275 Primary

  Genetically modified vertebrates, e.g. transgenic · CPC title

• A01K2217/05

  Animals comprising random inserted nucleic acids (transgenic) · CPC title

• C12Q1/6827 Primary

  for detection of mutation or polymorphism · CPC title